1.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PDT for Lip, NCT00868088
|
|
2.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 51439, NCT00571974
|
|
3.
|
Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CASE-1305, CASE1305, NCT00752323
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 30 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DUSA-PDT-BCC-06, DUSA-PDT-BCC-06, NCT00747903
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: DUSA-CP0104, NCT00865878
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 104974, NCT00961090
|
|
7.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NU-NWU05-5-01, NWU05-5-01, NWU 05-5-01, NCT00571558
|
|
8.
|
Phase: Phase I
Type: Diagnostic, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: 4079, NCT00671710
|
|
9.
|
Phase: Phase I
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: DMS 0711, R01 NS052274-01A2, NCT00870779
|
|
10.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UPCC-18308, UPCC 18308, IRB #809093, NCT00978081
|
|
11.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 18308, NCT01019954
|
|
12.
|
Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CASE-9Z07-CC417, CASE 9Z07-CC417, NCT00663910
|
